Hosted on MSN17h
The New Treatment Landscape in Seasonal Allergies
Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other ...
The Pharma Letter1h
Protega collaborates with Wellgistics for Roxybond launch
Privately-held US drugmaker Protega Pharmaceuticals, which recently launched Roxybond (oxycodone hydrochloride), the first ...